Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.

Saved in:
Bibliographic Details
Title: Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.
Authors: Pugliese N; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., White TM; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA., Brennan PN; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, Scotland, United Kingdom., Pannain S; Section of Endocrinology, Diabetes and Metabolism, University of Chicago Medicine, Chicago, IL, USA., Hagström H; Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Michel M; Department of Internal Medicine II, University Medical Centre Saarland, Homburg, Germany.; Faculty of Medicine, Saarland University, Saarbrücken, Germany., Rice-Duek L; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain., Targher G; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Verona, Italy.; Department of Medicine, University of Verona, Verona, Italy., Caussy C; Département Endocrinologie, Diabète et Nutrition, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, Lyon, France., Dillon JF; School of Medicine, University of Dundee, Dundee, United Kingdom., Tacke F; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Kopka CJ; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain., Sebastiani G; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada., Boursier J; Universitè d'Angers, HIFIH, SFR ICAT, Angers, France.; Department of Hepatogastroenterology, CHU Angers, Angers, France., Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Guaraldi G; Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy., Vettor R; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Center for Metabolic and Nutrition Related Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Thiele M; Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Roden M; Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; German Center for Diabetes Research (DZD), München-Neuherberg, Germany., Stefan N; Department of Internal Medicine IV, Division of Endocrinology, Diabetology, and Nephrology, University of Tübingen, Tübingen, Germany.; Institute of Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, Tübingen, Germany., Jarvis H; Population and Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Gines P; Liver Unit, Hospital Clínic of Barcelona, Barcelona, Spain., Schattenberg JM; Department of Internal Medicine II, University Medical Centre Saarland, Homburg, Germany.; Faculty of Medicine, Saarland University, Saarbrücken, Germany., Pose E; Liver Unit, Hospital Clínic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain., Buttigieg S; Digital Public Health Task Force, Association of Schools of Public Health in the European Region (ASPHER), Brussels, Belgium.; Ministry for Health and Active Ageing, Valletta, Malta., Byrne CD; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; National Institute for Health and Care Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom., Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.; Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.; Chair, The Lancet Regional Health - Europe Series on chronic liver disease in Europe.
Source: The Lancet regional health. Europe [Lancet Reg Health Eur] 2026 May 25; Vol. 65, pp. 101722. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-7762
DOI:10.1016/j.lanepe.2026.101722